BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 16, 2013
View Archived Issues
Novel potassium channel opener discovered at SciFluor Life Sciences
Read More
New genetic biomarker of survival in patients with idiopathic pulmonary fibrosis
Read More
A synergistic immunotherapy-mediated approach to target glioma growth
Read More
ADC Therapeutics and BZL Biologics enter license and collaboration agreement
Read More
Pfizer's tofacitinib citrate now approved in several additional countries
Read More
Data on ABT-267 alone and in combination therapy reported at recent conferences
Read More
Clinical data presented on Upsher-Smith's drug formulations for epilepsy
Read More
Intellipharmaceutics provides updates on Rexista oxycodone technology development
Read More
Teva submits IND for RX-3117 for solid tumors
Read More
Seattle Genetics begins phase I trial of SGN-CD33A in AML
Read More
Furiex completes enrollment in phase III trials of eluxadoline
Read More
Dart Therapeutics begins phase Ib/IIa study of HT-100
Read More
Biogen presents in vivo and phase I pharmacokinetic results for BIIB-037
Read More
Erivedge receives conditional E.U. approval
Read More
FDA grants QIDP designation to eravacycline
Read More
NCIC Clinical Trials Group to conduct phase II DPX-Survivac study
Read More
NeoStem forms regulatory T-cell collaboration with UCSF
Read More
Zealand Pharma and Boehringer Ingelheim design new GLP-1 and GL receptor agonists
Read More
Achillion Pharmaceuticals presents novel antibacterial agents
Read More
Researchers at Redx Pharma prepare novel agents for influenza virus infection
Read More
New hVps34 inhibitors disclosed by Millennium Pharmaceuticals
Read More
Shin Nippon Biomedical Laboratories and RIKEN execute research agreement
Read More
Pfizer synthesizes new sodium channel blockers
Read More
Alize Pharma begins first phase I trial of unacylated ghrelin analogue
Read More
Ocera Therapeutics and Tranzyme complete merger
Read More